These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 38445509

  • 1. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N, Yamamoto H, Kuga R, Jiromaru R, Hongo T, Katayama Y, Sonoda K, Yahata H, Kato K, Oda Y.
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [Abstract] [Full Text] [Related]

  • 2. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM.
    Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
    [Abstract] [Full Text] [Related]

  • 3. p16 overexpression and Rb loss correlate with high-risk HPV infection in oropharyngeal squamous cell carcinoma.
    Jiromaru R, Yamamoto H, Yasumatsu R, Hongo T, Nozaki Y, Nakano T, Hashimoto K, Nakagawa T, Oda Y.
    Histopathology; 2021 Sep; 79(3):358-369. PubMed ID: 33450095
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S, Barsan I, Hoang L, Patel P, Chiriboga L, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [Abstract] [Full Text] [Related]

  • 5. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Wada T, Ohishi Y, Kaku T, Aman M, Imamura H, Yasutake N, Sonoda K, Kato K, Oda Y.
    Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
    [Abstract] [Full Text] [Related]

  • 6. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [Abstract] [Full Text] [Related]

  • 7. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
    [Abstract] [Full Text] [Related]

  • 8. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM.
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [Abstract] [Full Text] [Related]

  • 9. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ, Kiyokawa T, Soslow RA, Lamb CA, Oliva E, Zivanovic O, Juretzka MM, Pirog EC.
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [Abstract] [Full Text] [Related]

  • 10. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
    Houghton O, Jamison J, Wilson R, Carson J, McCluggage WG.
    Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
    [Abstract] [Full Text] [Related]

  • 11. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Kong CS, Beck AH, Longacre TA.
    Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
    [Abstract] [Full Text] [Related]

  • 12. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [Abstract] [Full Text] [Related]

  • 13. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
    Milde-Langosch K, Riethdorf S, Kraus-Pöppinghaus A, Riethdorf L, Löning T.
    Virchows Arch; 2001 Jul; 439(1):55-61. PubMed ID: 11499840
    [Abstract] [Full Text] [Related]

  • 14. HPV-related Sinonasal Carcinoma: Clinicopathologic Features, Diagnostic Utility of p16 and Rb Immunohistochemistry, and EGFR Copy Number Alteration.
    Jiromaru R, Yamamoto H, Yasumatsu R, Hongo T, Nozaki Y, Hashimoto K, Taguchi K, Masuda M, Nakagawa T, Oda Y.
    Am J Surg Pathol; 2020 Mar; 44(3):305-315. PubMed ID: 31743130
    [Abstract] [Full Text] [Related]

  • 15. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
    Zhang CN, Liu XY, Li Q, Song YZ, Liu B, Yin J, Yang JH, Zhong L, Sun L, Zhang X, Chen W.
    Zhonghua Zhong Liu Za Zhi; 2023 May 23; 45(5):402-409. PubMed ID: 37188625
    [Abstract] [Full Text] [Related]

  • 16. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
    da Mata S, Ferreira J, Nicolás I, Esteves S, Esteves G, Lérias S, Silva F, Saco A, Cochicho D, Cunha M, Del Pino M, Ordi J, Félix A.
    Int J Mol Sci; 2021 Feb 25; 22(5):. PubMed ID: 33669021
    [Abstract] [Full Text] [Related]

  • 17. Detection of high-risk human papillomavirus DNA and immunohistochemical expressions of p16, vimentin, ER, and PR in primary endocervical and endometrial adenocarcinomas.
    Xiong Y, Xiong YY, Xu ZG.
    Eur J Gynaecol Oncol; 2016 Aug 25; 37(4):517-521. PubMed ID: 29894077
    [Abstract] [Full Text] [Related]

  • 18. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
    Elishaev E, Gilks CB, Miller D, Srodon M, Kurman RJ, Ronnett BM.
    Am J Surg Pathol; 2005 Mar 25; 29(3):281-94. PubMed ID: 15725796
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
    Jones MW, Onisko A, Dabbs DJ, Elishaev E, Chiosea S, Bhargava R.
    Int J Gynecol Cancer; 2013 Feb 25; 23(2):380-4. PubMed ID: 23318908
    [Abstract] [Full Text] [Related]

  • 20. [p16 and PR immunoreactivity and human papillomavirus infection in endocervical adenocarcinoma].
    Liu X, Li Q, Chen W, Li L, Shen G, Zhang X.
    Zhonghua Zhong Liu Za Zhi; 2014 Apr 25; 36(4):263-7. PubMed ID: 24989911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.